3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

PHASE3TerminatedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

September 6, 2012

Primary Completion Date

January 23, 2014

Study Completion Date

January 23, 2014

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Previous treatment in DEB025 study

Follow-up after DEB025 active study

Trial Locations (40)

640

Novartis Investigative Site, Douliu

1097

Novartis Investigative Site, Budapest

2145

Novartis Investigative Site, Westmead

3000

Novartis Investigative Site, Leuven

10126

Novartis Investigative Site, Torino

13353

Novartis Investigative Site, Berlin

20099

Novartis Investigative Site, Hamburg

24146

Novartis Investigative Site, Kiel

27100

Novartis Investigative Site, Pavia

30625

Novartis Investigative Site, Hanover

33305

Novartis Investigative Site, Linkou District

40447

Novartis Investigative Site, Taichung

43100

Novartis Investigative Site, Parma

49241

Novartis Investigative Site, Busan

50937

Novartis Investigative Site, Cologne

62703

Novartis Investigative Site, Springfield

76012

Novartis Investigative Site, Arlington

77030

Novartis Investigative Site, Houston

78215

Novartis Investigative Site, San Antonio

79106

Novartis Investigative Site, Freiburg im Breisgau

80756

Novartis Investigative Site, Kaohsiung City

83301

Novartis Investigative Site, Kaohsiung City

90110

Novartis Investigative Site, Songkhla

92101

Novartis Investigative Site, San Diego

93003

Novartis Investigative Site, Ventura

96814

Novartis Investigative Site, Honolulu

700506

Novartis Investigative Site, Iași

M5G 2C4

Novartis Investigative Site, Torono

400 036

Novartis Investigative Site, Mumbai

00161

Novartis Investigative Site, Roma

15-540

Novartis Investigative Site, Bialystok

01-201

Novartis Investigative Site, Warsaw

00909

Novartis Investigative Site, San Juan

050524

Novartis Investigative Site, Bucharest

030317

Novartis Investigative Site, Bucharest

020125

Novartis Investigative Site, Bucharest

021105

Novartis Investigative Site, Bucharest

614-735

Novartis Investigative Site, Pusan

08035

Novartis Investigative Site, Barcelona

Unknown

Novartis Investigative Site, Ho Chi Minh City

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY